Association between renin-angiotensin system blockade discontinuation and all-cause mortality among persons with low estimated glomerular filtration rate Y Qiao, JI Shin, TK Chen, LA Inker, J Coresh, GC Alexander, JW Jackson, ... JAMA internal medicine 180 (5), 718-726, 2020 | 148 | 2020 |
Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis KKW Chan, H Guo, S Cheng, JM Beca, R Redmond‐Misner, ... Cancer medicine 9 (1), 160-169, 2020 | 80 | 2020 |
Discontinuation of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease Y Qiao, JI Shin, Y Sang, LA Inker, A Secora, S Luo, J Coresh, ... Mayo Clinic Proceedings 94 (11), 2220-2229, 2019 | 51 | 2019 |
Birth Outcomes of Foreign‐Born, Native‐Born, and Mixed Couples in S weden ML Urquia, Y Qiao, JG Ray, C Liu, A Hjern Paediatric and perinatal epidemiology 29 (2), 123-130, 2015 | 40 | 2015 |
Surveillance in patients with Barrett's esophagus for early detection of esophageal adenocarcinoma: a systematic review and meta-analysis Y Qiao, A Hyder, SJ Bae, W Zarin, TJ O'neill, NE Marcon, L Stein, ... Clinical and translational gastroenterology 6 (12), e131, 2015 | 38 | 2015 |
Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting HH Thein, Y Qiao, A Zaheen, N Jembere, G Sapisochin, KKW Chan, ... PloS one 12 (10), e0185198, 2017 | 30 | 2017 |
Effect of socioeconomic status on hepatocellular carcinoma incidence and stage at diagnosis, a population‐based cohort study K Anyiwe, Y Qiao, P De, EM Yoshida, CC Earle, HH Thein Liver International 36 (6), 902-910, 2016 | 26 | 2016 |
Factors associated with patient trust in electronic health records used in primary care settings Y Qiao, O Asan, E Montague Health Policy and Technology 4 (4), 357-363, 2015 | 25 | 2015 |
Hyperkalemia and acute kidney injury with spironolactone use among patients with heart failure AM Secora, JI Shin, Y Qiao, GC Alexander, AR Chang, LA Inker, J Coresh, ... Mayo Clinic Proceedings 95 (11), 2408-2419, 2020 | 19 | 2020 |
Cost‐effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person‐level data in a Canadian setting HH Thein, W Isaranuwatchai, Y Qiao, K Wong, G Sapisochin, KKW Chan, ... Cancer Medicine 6 (9), 2017-2033, 2017 | 19 | 2017 |
Are population‐based patient‐reported outcomes associated with overall survival in patients with advanced pancreatic cancer? WF Dai, J Beca, H Guo, W Isaranawatchai, D Schwartz, R Naipaul, J Arias, ... Cancer medicine 9 (1), 215-224, 2020 | 16 | 2020 |
Association of albuminuria levels with the prescription of renin-angiotensin system blockade Y Qiao, JI Shin, TK Chen, Y Sang, J Coresh, JA Vassalotti, AR Chang, ... Hypertension 76 (6), 1762-1768, 2020 | 14 | 2020 |
Globalization of clinical trials: Variation in estimated regional costs of pivotal trials, 2015–2016 Y Qiao, GC Alexander, TJ Moore Clinical Trials 16 (3), 329-333, 2019 | 14 | 2019 |
Trends in health care utilization and costs attributable to hepatocellular carcinoma, 2002–2009: a population-based cohort study HH Thein, Y Qiao, SK Young, W Zarin, EM Yoshida, C de Oliveira, ... Current oncology 23 (3), 196-220, 2016 | 12 | 2016 |
Improved survival in overweight and obese patients with aggressive B-cell lymphoma treated with rituximab-containing chemotherapy for curative intent JKR Stevenson, Y Qiao, KKW Chan, J Beca, W Isaranuwatchai, H Guo, ... Leukemia & lymphoma 60 (6), 1399-1408, 2019 | 8 | 2019 |
Preterm disparities between foreign and Swedish born mothers depend on the method used to estimate gestational age. A Swedish population-based register study SP Juárez, ML Urquia, E Mussino, C Liu, Y Qiao, A Hjern Plos one 16 (2), e0247138, 2021 | 4 | 2021 |
Comparative effectiveness and safety of the implementation of universal public funding of FOLFIRINOX (FFX) and gemcitabine (G)+ nab-paclitaxel (GnP) in advanced pancreatic … H Guo, JM Beca, R Redmond-Misner, W Isaranuwatchai, L Qiao, C Earle, ... Journal of Clinical Oncology 36 (4_suppl), 375-375, 2018 | 1 | 2018 |
Outcomes of FOLFIRINOX (FFX) and gemcitabine+ nab-paclitaxel (GnP) in initially unresectable locally advanced pancreatic cancer (uLAPC): A population-based study. KK Chan, H Guo, JM Beca, R Redmond-Misner, W Isaranuwatchai, ... Journal of Clinical Oncology 35 (4_suppl), 394-394, 2017 | 1 | 2017 |
Abstract P147: Association Of Rosuvastatin Use With Risk Of Rhabdomyolysis Across Chronic Kidney Disease Status JI Shin, Y Qiao, A Surapaneni, L Inker, D Fine, T Nolin, AR Chang, ... Circulation 143 (Suppl_1), AP147-AP147, 2021 | | 2021 |
STOPPING MINERALOCORTICOID RECEPTOR ANTAGONISTS AFTER HYPERKALEMIA AND RISK OF ADVERSE OUTCOMES IN PATIENTS WITH HEART FAILURE M Trevisan, Y Xu, Y Qiao, G Savarese, L Lund, M Grams, A Sjolander, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 35, 1097-1097, 2020 | | 2020 |